delta-n-methylarginine has been researched along with dactinomycin in 1 studies
Studies (delta-n-methylarginine) | Trials (delta-n-methylarginine) | Recent Studies (post-2010) (delta-n-methylarginine) | Studies (dactinomycin) | Trials (dactinomycin) | Recent Studies (post-2010) (dactinomycin) |
---|---|---|---|---|---|
10 | 0 | 0 | 19,045 | 355 | 969 |
Protein | Taxonomy | delta-n-methylarginine (IC50) | dactinomycin (IC50) |
---|---|---|---|
RAD51 | Homo sapiens (human) | 32.1 | |
Growth factor receptor-bound protein 2 | Homo sapiens (human) | 5 | |
Discoidin domain-containing receptor 2 | Homo sapiens (human) | 9 | |
Growth factor receptor-bound protein 2 | Mus musculus (house mouse) | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Durante, W; Peyton, KJ; Schafer, AI | 1 |
1 other study(ies) available for delta-n-methylarginine and dactinomycin
Article | Year |
---|---|
Platelet-derived growth factor stimulates heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells.
Topics: Animals; Aorta, Thoracic; Arginine; Carbon Monoxide; Cells, Cultured; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Protein Synthesis Inhibitors; Rats; RNA, Messenger | 1999 |